Study of Mitomycin-C Application in Laryngotracheal Stenosis

Summary

This is a randomized, prospective, double-blind, placebo-controlled clinical trial of the use of mitomycin-C topical application as an adjunctive treatment in the endoscopic surgical treatment of patients with laryngotracheal stenosis. We hypothesize that the use of mitomycin-C improves patient outcome in the endoscopic surgical treatment of laryngotracheal stenosis.

Timeline

Start

2012-08

Primary completion

2018-02

Completion

2018-02

Outcome

Outcome not reported

Stopped (Enrollment): “Due to poor patient accrual, the study was closed prior to reaching the desired study size”

Drugs

Indications